CUBE LABS COVID-19 RESPONSE

On March 11, 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a pandemic. Along with the wider scientific community, we are committed to doing everything we can at Cube Labs to address this rapidly evolving, global health crisis.

Cube Labs portfolio companies, Adamas and DTech, have allied to develop a prophylactic technology to combat COVID-19, with the goal of creating a novel medical device that prevents virus particles from infecting host cells.

To learn more about Cube Labs’ response to the COVID-19 crisis, Contact Us.

[LOGO-DESIGN]-CUBE-LABS-HD

Offices

Lecce, 73100 Via Filippo Smaldone, 13

lecce.office@cube-labs.com

 

Milan, 20121 Via Palermo, 8

milan.office@cube-labs.com

Legal seat
Rome, 00186 Giulio Caccini, 1

rome.office@cube-labs.com

Careers

Privacy & Cokies Policy

Close Menu